Abstract
Methamphetamine (MAP) dependence is a highly heritable and aberrant dopaminergic signaling that has been implicated in the disease. Glial cell line-derived neurotrophic factor (GDNF), which plays an important role in the survival of dopaminergic neurons, may be involved in this disorder. In this study, we examined the association between GDNF and MAP dependence using a Japanese population-based sample. We selected eight single nucleotide polymorphisms (SNPs) in the GDNF locus for the association analysis. When patients with MAP dependence were divided into two subgroups consisting of multi-substance and MAP-only users, we detected a significant association between these two groups and the tagging SNP, rs2910704 (after Bonferroni's correction; allele P = 0.034). Thus, GDNF is likely to be related to the severity of MAP use in the Japanese population.
| Original language | English |
|---|---|
| Pages (from-to) | 1268-1272 |
| Number of pages | 5 |
| Journal | Progress in Neuro-Psychopharmacology and Biological Psychiatry |
| Volume | 35 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - 01-07-2011 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Pharmacology
- Biological Psychiatry
Cite this
}
Association analysis of the GDNF gene with methamphetamine use disorder in a Japanese population. / Yoshimura, Tomoko; Usui, Hinako; Takahashi, Nagahide; Yoshimi, Akira; Saito, Shinichi; Aleksic, Branko; Ujike, Hiroshi; Inada, Toshiya; Yamada, Mitsuhiko; Uchimura, Naohisa; Iwata, Nakao; Sora, Ichiro; Iyo, Masaomi; Ozaki, Norio.
In: Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 35, No. 5, 01.07.2011, p. 1268-1272.Research output: Contribution to journal › Article
TY - JOUR
T1 - Association analysis of the GDNF gene with methamphetamine use disorder in a Japanese population
AU - Yoshimura, Tomoko
AU - Usui, Hinako
AU - Takahashi, Nagahide
AU - Yoshimi, Akira
AU - Saito, Shinichi
AU - Aleksic, Branko
AU - Ujike, Hiroshi
AU - Inada, Toshiya
AU - Yamada, Mitsuhiko
AU - Uchimura, Naohisa
AU - Iwata, Nakao
AU - Sora, Ichiro
AU - Iyo, Masaomi
AU - Ozaki, Norio
PY - 2011/7/1
Y1 - 2011/7/1
N2 - Methamphetamine (MAP) dependence is a highly heritable and aberrant dopaminergic signaling that has been implicated in the disease. Glial cell line-derived neurotrophic factor (GDNF), which plays an important role in the survival of dopaminergic neurons, may be involved in this disorder. In this study, we examined the association between GDNF and MAP dependence using a Japanese population-based sample. We selected eight single nucleotide polymorphisms (SNPs) in the GDNF locus for the association analysis. When patients with MAP dependence were divided into two subgroups consisting of multi-substance and MAP-only users, we detected a significant association between these two groups and the tagging SNP, rs2910704 (after Bonferroni's correction; allele P = 0.034). Thus, GDNF is likely to be related to the severity of MAP use in the Japanese population.
AB - Methamphetamine (MAP) dependence is a highly heritable and aberrant dopaminergic signaling that has been implicated in the disease. Glial cell line-derived neurotrophic factor (GDNF), which plays an important role in the survival of dopaminergic neurons, may be involved in this disorder. In this study, we examined the association between GDNF and MAP dependence using a Japanese population-based sample. We selected eight single nucleotide polymorphisms (SNPs) in the GDNF locus for the association analysis. When patients with MAP dependence were divided into two subgroups consisting of multi-substance and MAP-only users, we detected a significant association between these two groups and the tagging SNP, rs2910704 (after Bonferroni's correction; allele P = 0.034). Thus, GDNF is likely to be related to the severity of MAP use in the Japanese population.
UR - http://www.scopus.com/inward/record.url?scp=79957863625&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79957863625&partnerID=8YFLogxK
U2 - 10.1016/j.pnpbp.2011.04.003
DO - 10.1016/j.pnpbp.2011.04.003
M3 - Article
VL - 35
SP - 1268
EP - 1272
JO - Progress in Neuro-Psychopharmacology and Biological Psychiatry
JF - Progress in Neuro-Psychopharmacology and Biological Psychiatry
SN - 0278-5846
IS - 5
ER -